logo-loader

Horizon Discovery directors show faith with share buys

Published: 13:25 02 Dec 2016 GMT

empt_boardroom,_sized_584177011e0aa
There were director share buys aplenty at Horizon

Directors at gene editing group Horizon Discovery Group PLC (LON:HZD) have shown the faith and bought shares in the firm worth over £246,000.

Chief executive Dr Darrin Disley, chairman Dr Ian Gilham, directors Dr Jonathan Milner and Mrs Susan Searle and chief financial officer Richard Vellacott all made share purchases totalling around £198,000.

In a separate statement the firm said director Dr Susan Galbraith had bought shares worth almost £48,000.

Last month, the group said it had entered the Chinese market by striking deals with three leading diagnostic kit manufacturers.

It will provide its HDx reference cell lines to be used to develop assays, for use in clinical trials, and ultimately to be used in-kit controls under original equipment manufacturer (OEM) agreements. It will receive upfront revenue.

Significantly, these early steps have led to the company being approached for further partnerships with 20-30 other players in a market, which is expected to reach US$10bn by 2021.

Horizon shares eased 0.43% on the day to stand at 117p.

Acquisition gives Horizon Discovery a 'full and complete suite of tools' to...

Chris Claxton, VP Investor Relations & Corporate Communications at Horizon Discovery Group PLC (LON:HZD), discusses with Proactive their 'transformational' acquisition of GE healthcare business Dharmacon. The US$85mln deal was announced in July and funded through cash and shares and...

on 4/9/17